188 related articles for article (PubMed ID: 16102623)
1. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
J Vasc Surg; 2005 Aug; 42(2):252-8. PubMed ID: 16102623
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty.
Cassar K; Ford I; Greaves M; Bachoo P; Brittenden J
Br J Surg; 2005 Feb; 92(2):159-65. PubMed ID: 15609386
[TBL] [Abstract][Full Text] [Related]
3. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
Wilson AM; Brittenden J; Bachoo P; Ford I; Nixon GF
J Vasc Surg; 2009 Oct; 50(4):861-9. PubMed ID: 19786240
[TBL] [Abstract][Full Text] [Related]
5. Variability in responsiveness to clopidogrel in patients with intermittent claudication.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):71-5. PubMed ID: 16549375
[TBL] [Abstract][Full Text] [Related]
6. The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty.
Hobbs SD; Marshall T; Fegan C; Adam DJ; Bradbury AW
J Vasc Surg; 2006 Jan; 43(1):40-6. PubMed ID: 16414385
[TBL] [Abstract][Full Text] [Related]
7. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
[TBL] [Abstract][Full Text] [Related]
8. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the clopidogrel-proton pump inhibitor interaction after peripheral endovascular intervention for claudication.
Meltzer AJ; Da Silva P; Schneider DB; Shrikhande GV
Vasc Endovascular Surg; 2012 Oct; 46(7):524-9. PubMed ID: 22989428
[TBL] [Abstract][Full Text] [Related]
10. Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state.
Collins P; Ford I; Greaves M; Macaulay E; Brittenden J
Platelets; 2006 Aug; 17(5):311-7. PubMed ID: 16928603
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
13. Prolonged application of clopidogrel reduces inflammation after percutaneous coronary intervention in the porcine model.
Ayral Y; Rauch U; Goldin-Lang P; Stellbaum C; Deiner C; Schwimmbeck PL; Schultheiss HP; Pels K
Cardiovasc Revasc Med; 2007; 8(3):183-8. PubMed ID: 17765648
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
15. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Valgimigli M; Campo G; de Cesare N; Meliga E; Vranckx P; Furgieri A; Angiolillo DJ; Sabatè M; Hamon M; Repetto A; Colangelo S; Brugaletta S; Parrinello G; Percoco G; Ferrari R;
Circulation; 2009 Jun; 119(25):3215-22. PubMed ID: 19528337
[TBL] [Abstract][Full Text] [Related]
16. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention.
Quinn MJ; Bhatt DL; Zidar F; Vivekananthan D; Chew DP; Ellis SG; Plow E; Topol EJ
Am J Cardiol; 2004 Mar; 93(6):679-84. PubMed ID: 15019868
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
20. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
